Japan Revises the Requirements for Quasi-drugs
Apr 11, 2023
MHLW announced unifying the description of reagents and test solutions in JSQI 2021 with other regulations, such as the Japanese Pharmacopeia, etc. The application requirements for manufacturing and sales license were revised correspondingly.
On March 27, 2023, MHLW issued Notification 0327 No. 1 and Notification 0327 No. 5, including minor adjustments to reagents and test solutions in Japanese Standards of Quasi-drug Ingredients 2021 (hereinafter the "JSQI 2021") and revision to the application for manufacturing and sales license. These amendments came into effect upon its publication on March 27, but the previous provisions can still be applied before September 30, 2024.
Please Log in
or Sign up
(FREE) to read the full content.
We provide full-scale Chinese cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by email@example.com
Copyright: unless otherwise stated all contents of this website are ©2023 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact firstname.lastname@example.org